Annual Operating Profit
-$46.95 M
+$4.28 M+8.35%
December 31, 2023
Summary
- As of February 7, 2025, GRTX annual operating income is -$46.95 million, with the most recent change of +$4.28 million (+8.35%) on December 31, 2023.
- During the last 3 years, GRTX annual operating profit has risen by +$23.60 million (+33.45%).
- GRTX annual operating profit is now -94.87% below its all-time high of -$24.09 million, reached on December 31, 2017.
Performance
GRTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$3.74 M
+$465.00 K+11.05%
September 1, 2024
Summary
- As of February 7, 2025, GRTX quarterly operating income is -$3.74 million, with the most recent change of +$465.00 thousand (+11.05%) on September 1, 2024.
- Over the past year, GRTX quarterly operating profit has increased by +$1.43 million (+27.67%).
- GRTX quarterly operating profit is now at all-time high.
Performance
GRTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$17.71 M
+$7.34 M+29.31%
September 1, 2024
Summary
- As of February 7, 2025, GRTX TTM operating income is -$17.71 million, with the most recent change of +$7.34 million (+29.31%) on September 1, 2024.
- Over the past year, GRTX TTM operating profit has increased by +$29.25 million (+62.29%).
- GRTX TTM operating profit is now -227.46% below its all-time high of -$5.41 million, reached on September 30, 2018.
Performance
GRTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
GRTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.3% | +27.7% | +62.3% |
| 3 y3 years | +33.5% | +27.7% | +62.3% |
| 5 y5 years | -93.6% | +27.7% | +62.3% |
GRTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.0% | at high | +77.7% | at high | +75.9% |
| 5 y | 5-year | at high | +36.0% | at high | +82.3% | at high | +77.3% |
| alltime | all time | -94.9% | +36.0% | at high | +82.3% | -227.5% | +77.3% |
Galera Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.74 M(-11.0%) | -$17.71 M(-29.3%) |
| Jun 2024 | - | -$4.21 M(-8.0%) | -$25.05 M(-33.5%) |
| Mar 2024 | - | -$4.58 M(-11.6%) | -$37.65 M(-19.8%) |
| Dec 2023 | -$46.95 M(-8.3%) | -$5.18 M(-53.3%) | -$46.95 M(-14.6%) |
| Sep 2023 | - | -$11.09 M(-34.0%) | -$54.96 M(-3.3%) |
| Jun 2023 | - | -$16.81 M(+21.1%) | -$56.83 M(+9.4%) |
| Mar 2023 | - | -$13.88 M(+5.3%) | -$51.95 M(+1.4%) |
| Dec 2022 | -$51.23 M(-30.2%) | -$13.19 M(+1.8%) | -$51.23 M(-2.5%) |
| Sep 2022 | - | -$12.96 M(+8.6%) | -$52.54 M(-12.3%) |
| Jun 2022 | - | -$11.93 M(-9.3%) | -$59.88 M(-13.3%) |
| Mar 2022 | - | -$13.15 M(-9.3%) | -$69.04 M(-5.9%) |
| Dec 2021 | -$73.37 M | -$14.50 M(-28.6%) | -$73.37 M(-5.7%) |
| Sep 2021 | - | -$20.30 M(-3.7%) | -$77.81 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$21.09 M(+20.6%) | -$73.59 M(+4.8%) |
| Mar 2021 | - | -$17.48 M(-7.7%) | -$70.22 M(-0.5%) |
| Dec 2020 | -$70.55 M(+39.2%) | -$18.94 M(+17.8%) | -$70.55 M(+4.1%) |
| Sep 2020 | - | -$16.08 M(-9.2%) | -$67.78 M(+5.0%) |
| Jun 2020 | - | -$17.71 M(-0.6%) | -$64.56 M(+11.1%) |
| Mar 2020 | - | -$17.82 M(+10.2%) | -$58.11 M(+14.6%) |
| Dec 2019 | -$50.69 M(+109.0%) | -$16.17 M(+25.8%) | -$50.69 M(+16.9%) |
| Sep 2019 | - | -$12.86 M(+14.1%) | -$43.38 M(+20.7%) |
| Jun 2019 | - | -$11.27 M(+8.4%) | -$35.93 M(+45.7%) |
| Mar 2019 | - | -$10.40 M(+17.4%) | -$24.66 M(+72.9%) |
| Dec 2018 | -$24.25 M(+0.7%) | -$8.86 M(+63.8%) | -$14.27 M(+163.8%) |
| Sep 2018 | - | -$5.41 M | -$5.41 M |
| Dec 2017 | -$24.09 M | - | - |
FAQ
- What is Galera Therapeutics annual operating income?
- What is the all time high annual operating profit for Galera Therapeutics?
- What is Galera Therapeutics annual operating profit year-on-year change?
- What is Galera Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Galera Therapeutics?
- What is Galera Therapeutics quarterly operating profit year-on-year change?
- What is Galera Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Galera Therapeutics?
- What is Galera Therapeutics TTM operating profit year-on-year change?
What is Galera Therapeutics annual operating income?
The current annual operating profit of GRTX is -$46.95 M
What is the all time high annual operating profit for Galera Therapeutics?
Galera Therapeutics all-time high annual operating income is -$24.09 M
What is Galera Therapeutics annual operating profit year-on-year change?
Over the past year, GRTX annual operating income has changed by +$4.28 M (+8.35%)
What is Galera Therapeutics quarterly operating income?
The current quarterly operating profit of GRTX is -$3.74 M
What is the all time high quarterly operating profit for Galera Therapeutics?
Galera Therapeutics all-time high quarterly operating income is -$3.74 M
What is Galera Therapeutics quarterly operating profit year-on-year change?
Over the past year, GRTX quarterly operating income has changed by +$1.43 M (+27.67%)
What is Galera Therapeutics TTM operating income?
The current TTM operating profit of GRTX is -$17.71 M
What is the all time high TTM operating profit for Galera Therapeutics?
Galera Therapeutics all-time high TTM operating income is -$5.41 M
What is Galera Therapeutics TTM operating profit year-on-year change?
Over the past year, GRTX TTM operating income has changed by +$29.25 M (+62.29%)